Home
TCG Crossover GP II reported a 4.2% stake in Alx Oncology Holdings ALXO · 5,655,487 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.2%
- Last report
- 9.9% · filed 26/02/06
- Shares held
- 5,655,487 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- TCG Crossover GP II
- Event date
- 26/06/30
- Filed
- 26/08/14
4.2% stake · below 5%
- Stake
- 4.2%
- Last report
- 9.9%
- Since last report
- −5.7pp
Alx Oncology Holdings trades, last 26 weeks
What else happened in Alx Oncology Holdings around then
Filed or reported within 30 days of the trade day · 05/31~07/30TCG Crossover GP II's other 5% stake reports
- TCG Crossover GP II
5% stakeFirst Tracks Biotherapeutics
5% stakeFirst Tracks Biotherapeutics
TRAX
8.3% stake
2,895,304 sh
8.3% stake
Filed 08/14
- TCG Crossover GP II
5% stakeFulcrum Therapeutics
5% stakeFulcrum Therapeutics
FULC
0% stake
0 sh
0% stake
Filed 08/14
- TCG Crossover GP II
5% stakeLB Pharmaceuticals
5% stakeLB Pharmaceuticals
LBRX
5% stake
1,447,310 sh
5% stake
Filed 08/14
- TCG Crossover GP II
5% stakeTango Therapeutics
5% stakeTango Therapeutics
TNGX
7% stake
10,147,867 sh
7% stake
Filed 08/14
- TCG Crossover GP II
5% stakeSurrozen
5% stakeSurrozen
SRZN
9.9% stake
1,148,101 sh
9.9% stake
Filed 07/24
